Bone Biologics Corporation
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
1.81M
on 2026-06-30, from 169K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-6 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
$1.1M
H.C. Wainwright, agreement of 2024-09-27. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-14 is not read yet.
Cash
Four quarters of operating cash flow to 2023-03-31 are not all on file.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-06-27 | Public offering with warrants at $4.00 | not read | $4.00 | $5.0M | 424B4 ↗ |